[Malignant hyperthermia, syndrome malin, and heat stroke].
D000293:Adolescent; D000328:Adult; D000769:Anesthesia, Inhalation / Q000009:adverse effects / Q000662:veterinary; D000818:Animals; D002118:Calcium / Q000378:metabolism; D003402:Creatine Kinase / Q000097:blood; D006221:Halothane / Q000009:adverse effects; D006359:Heat Exhaustion / Q000209:etiology*; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology*; D009119:Muscle Contraction; D009132:Muscles / Q000378:metabolism; D009135:Muscular Diseases / Q000150:complications / Q000201:enzymology; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects; D009497:Neurotic Disorders / Q000150:complications; D013315:Stress, Psychological / Q000503:physiopathology; D013390:Succinylcholine / Q000009:adverse effects; D013552:Swine
D009466:Neuromuscular Blocking Agents; D003402:Creatine Kinase; D013390:Succinylcholine; D002118:Calcium; D006221:Halothane